Patient Health is our focus
and medical excellence is our goal.
The Science Behind Suisselle
CHAC (Crosslinked Hyaluronic Acid Compositions) Technology* enhances and exploits the natural properties of HA both making it an optimal vehicle for transporting essential nutrients to the skin and ensuring their effective delivery, all while minimizing their degradation.
In order to obtain such results, the mixture undergoes simultaneous pressure and shear deformation, which results in molecular complexes. The additives, which are mostly small organic molecules, stabilize the HA to increase the bioavailability of the additives and provide long-lasting effects.
Our R&D department has a wealth of knowledge, including both clinical and practical experience, exploring the many advantages of Hyaluronic Acid (HA).
Their vast knowledge of the HA molecule places us at the forefront of new discoveries and HA applications.
Crosslinked Hyaluronic Acid Compositions, an innovative and patented technology* has three phases: (1). HA matrix is formed (2). Crosslinked complexes are formed by integrating active ingredients into HA matrix (3). Three-dimensional molecular complex is formed. This process occurs in a clean, single step, solid state reaction utilizing simultaneous pressure and shear deformation. By way of these complexes, the HA becomes highly stabilized, similar to HA stabilization achieved with cross linking.
*European Patent Application No. 14788611.3, United States Patent Application No. 20160074519, WO2014/172784A1